U.S. markets closed
  • S&P 500

    3,841.94
    +73.47 (+1.95%)
     
  • Dow 30

    31,496.30
    +572.16 (+1.85%)
     
  • Nasdaq

    12,920.15
    +196.68 (+1.55%)
     
  • Russell 2000

    2,192.21
    +45.29 (+2.11%)
     
  • Crude Oil

    66.28
    +2.45 (+3.84%)
     
  • Gold

    1,698.20
    -2.50 (-0.15%)
     
  • Silver

    25.30
    -0.17 (-0.65%)
     
  • EUR/USD

    1.1925
    -0.0054 (-0.45%)
     
  • 10-Yr Bond

    1.5540
    +0.0040 (+0.26%)
     
  • GBP/USD

    1.3827
    -0.0067 (-0.48%)
     
  • USD/JPY

    108.2450
    +0.2690 (+0.25%)
     
  • BTC-USD

    48,743.24
    +815.28 (+1.70%)
     
  • CMC Crypto 200

    982.93
    +39.75 (+4.21%)
     
  • FTSE 100

    6,630.52
    -20.36 (-0.31%)
     
  • Nikkei 225

    28,864.32
    -65.78 (-0.23%)
     

Charles River Laboratories International Inc (CRL) Corporate Executive VP & CFO David Ross ...

GuruFocus.com
·2 min read

- By insider

Corporate Executive VP & CFO of Charles River Laboratories International Inc (30-Year Financial, Insider Trades) David Ross Smith (insider trades) sold 8,656 shares of CRL on 02/19/2021 at an average price of $290.63 a share. The total sale was $2.5 million.


Charles River Laboratories International Inc is a pharmaceutical company providing drug discovery and development services. The company provides animal models for laboratory testing, and offers manufacturing testing services to various industries. Charles River Laboratories International Inc has a market cap of $13.96 billion; its shares were traded at around $280.450000 with a P/E ratio of 38.95 and P/S ratio of 4.86. Charles River Laboratories International Inc had annual average EBITDA growth of 17.00% over the past five years. GuruFocus has detected 2 severe warning signs with Charles River Laboratories International Inc. .

CEO Recent Trades:

  • Chairman, President and CEO James C Foster sold 30,000 shares of CRL stock on 02/11/2021 at the average price of $285.02. The price of the stock has decreased by 1.6% since.

CFO Recent Trades:

  • Corporate Executive VP & CFO David Ross Smith sold 8,656 shares of CRL stock on 02/19/2021 at the average price of $290.63. The price of the stock has decreased by 3.5% since.

Directors and Officers Recent Trades:

  • Corporate Executive VP Birgit Girshick sold 1,675 shares of CRL stock on 02/19/2021 at the average price of $293.92. The price of the stock has decreased by 4.58% since.

  • CSVP&Chief Accounting Officer Michael Gunnar Knell sold 410 shares of CRL stock on 02/19/2021 at the average price of $290.99. The price of the stock has decreased by 3.62% since.

For the complete insider trading history of CRL, click here

.This article first appeared on GuruFocus.